These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 22879910
1. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression. Gross H, Hennard C, Masouris I, Cassel C, Barth S, Stober-Grässer U, Mamiani A, Moritz B, Ostareck D, Ostareck-Lederer A, Neuenkirchen N, Fischer U, Deng W, Leonhardt H, Noessner E, Kremmer E, Grässer FA. PLoS One; 2012; 7(8):e42106. PubMed ID: 22879910 [Abstract] [Full Text] [Related]
2. Antibodies against the mono-methylated arginine-glycine repeat (MMA-RG) of the Epstein-Barr virus nuclear antigen 2 (EBNA2) identify potential cellular proteins targeted in viral transformation. Ayoubian H, Fröhlich T, Pogodski D, Flatley A, Kremmer E, Schepers A, Feederle R, Arnold GJ, Grässer FA. J Gen Virol; 2017 Aug; 98(8):2128-2142. PubMed ID: 28758620 [Abstract] [Full Text] [Related]
3. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2). Gross H, Barth S, Pfuhl T, Willnecker V, Spurk A, Gurtsevitch V, Sauter M, Hu B, Noessner E, Mueller-Lantzsch N, Kremmer E, Grässer FA. Int J Cancer; 2011 Sep 01; 129(5):1105-15. PubMed ID: 21710493 [Abstract] [Full Text] [Related]
4. Asymmetric Arginine dimethylation of Epstein-Barr virus nuclear antigen 2 promotes DNA targeting. Gross H, Barth S, Palermo RD, Mamiani A, Hennard C, Zimber-Strobl U, West MJ, Kremmer E, Grässer FA. Virology; 2010 Feb 20; 397(2):299-310. PubMed ID: 19969318 [Abstract] [Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 2 binds via its methylated arginine-glycine repeat to the survival motor neuron protein. Barth S, Liss M, Voss MD, Dobner T, Fischer U, Meister G, Grässer FA. J Virol; 2003 Apr 20; 77(8):5008-13. PubMed ID: 12663808 [Abstract] [Full Text] [Related]
6. Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway. Fuentes-Pananá EM, Peng R, Brewer G, Tan J, Ling PD. J Virol; 2000 Sep 20; 74(17):8166-75. PubMed ID: 10933728 [Abstract] [Full Text] [Related]
7. Modulation of Epstein-Barr virus nuclear antigen 2-dependent transcription by protein arginine methyltransferase 5. Liu CD, Cheng CP, Fang JS, Chen LC, Zhao B, Kieff E, Peng CW. Biochem Biophys Res Commun; 2013 Jan 18; 430(3):1097-102. PubMed ID: 23261437 [Abstract] [Full Text] [Related]
8. Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions. Rowe M, Raithatha S, Shannon-Lowe C. J Virol; 2014 Oct 18; 88(20):12065-76. PubMed ID: 25122803 [Abstract] [Full Text] [Related]
9. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites. Wang A, Welch R, Zhao B, Ta T, Keleş S, Johannsen E. J Virol; 2015 Dec 30; 90(6):2906-19. PubMed ID: 26719268 [Abstract] [Full Text] [Related]
10. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter. Peng R, Moses SC, Tan J, Kremmer E, Ling PD. J Virol; 2005 Apr 30; 79(7):4492-505. PubMed ID: 15767449 [Abstract] [Full Text] [Related]
11. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells. Liu CD, Chen YL, Min YL, Zhao B, Cheng CP, Kang MS, Chiu SJ, Kieff E, Peng CW. PLoS Pathog; 2012 Apr 30; 8(12):e1003084. PubMed ID: 23271972 [Abstract] [Full Text] [Related]
12. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. Zimber-Strobl U, Kremmer E, Grässer F, Marschall G, Laux G, Bornkamm GW. EMBO J; 1993 Jan 30; 12(1):167-75. PubMed ID: 8381349 [Abstract] [Full Text] [Related]
13. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit. Ning S, Hahn AM, Huye LE, Pagano JS. J Virol; 2003 Sep 30; 77(17):9359-68. PubMed ID: 12915551 [Abstract] [Full Text] [Related]
14. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Portal D, Zhao B, Calderwood MA, Sommermann T, Johannsen E, Kieff E. Proc Natl Acad Sci U S A; 2011 May 10; 108(19):7808-13. PubMed ID: 21518914 [Abstract] [Full Text] [Related]
15. BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2. Harter MR, Liu CD, Shen CL, Gonzalez-Hurtado E, Zhang ZM, Xu M, Martinez E, Peng CW, Song J. PLoS Pathog; 2016 Feb 10; 12(2):e1005414. PubMed ID: 26845565 [Abstract] [Full Text] [Related]
16. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus. Pich D, Mrozek-Gorska P, Bouvet M, Sugimoto A, Akidil E, Grundhoff A, Hamperl S, Ling PD, Hammerschmidt W. mBio; 2019 Sep 17; 10(5):. PubMed ID: 31530670 [Abstract] [Full Text] [Related]
17. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes. Laux G, Dugrillon F, Eckert C, Adam B, Zimber-Strobl U, Bornkamm GW. J Virol; 1994 Nov 17; 68(11):6947-58. PubMed ID: 7933076 [Abstract] [Full Text] [Related]
18. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells. Wood CD, Carvell T, Gunnell A, Ojeniyi OO, Osborne C, West MJ. J Virol; 2018 Oct 01; 92(19):. PubMed ID: 30021904 [Abstract] [Full Text] [Related]
19. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2. Peng R, Tan J, Ling PD. J Virol; 2000 Nov 01; 74(21):9953-63. PubMed ID: 11024123 [Abstract] [Full Text] [Related]
20. Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter. Voss MD, Hille A, Barth S, Spurk A, Hennrich F, Holzer D, Mueller-Lantzsch N, Kremmer E, Grässer FA. J Virol; 2001 Dec 01; 75(23):11781-90. PubMed ID: 11689659 [Abstract] [Full Text] [Related] Page: [Next] [New Search]